The Group has invested heavily, especially in R&D, to offer the right products to meet the needs of professionals, notably in vaccines, reproduction and anti-infectives.
- The biological range offers vaccines to protect against respiratory diseases like COGLAPIX® (swine pleuropneumonia), HYOGEN® (enzootic pneumonia) and AUPHYL Plus® (Aujeszky’s disease) and COGLAPEST® (classical swine fever).
Ceva has completed the range of vaccines with CIRCOVAC® (PCV2), PARVOJECT® (parvovirus), and PROGRESSIS® (PRRS).
- The reproduction range now consists of ALTRESYN®, FERTIPIG® (serum and chorionic gonadotropins) ENZAPROST®T and FERTIPIG® (serum and chorionic gonadotropins). The range is completed with the inclusion of CEVAZURIL® (toltrazuril) against coccidiosis.
Ceva's anti-infectives are VETRIMOXIN®LA, (amoxicillin-based) and TENALIN® LA, (oxytetracycline-based) parenteral anti-microbials with fast syringeability, easy resuspendable formulation contained in innovative, practical, shock resistant, light and ergonomic CLAS vials.
The pharmaceutical line up includes the injectable non-steroidal anti-inflammatory drug (NSAID), GENIXINE® and antibiotic premixes TIAMVET®, MICLOZAN® and VETRIMOXIN®50.
From one country to another, product lines are adapted to local demand and regulatory requirements. For further information, please take a look at the Ceva Santé Animale site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorised persons.
Last update: 29/05/2018